Recent studies have shown that PPARα-deficient mice are remarkably sensitive to DEN(diethylnitrosamine)-induced liver cancer, and PPARα inhibits HCC development by mediating the NF-κB pathway (29). The gene discussed is NFKB1; the disease is liver cancer.